The Beckley Foundation's Program of Psychedelic Research - Amanda Feilding

Psilocybin acts as a powerful tool for exploring the neural correlates of consciousness. Functional MRI studies demonstrate that psilocybin reduces blood flow in key areas of the default mode network, fundamentally altering the brain's internal communication patterns and reducing connectivity between the medial prefrontal cortex and posterior cingulate cortex. MDMA is similarly highlighted for its potential in therapeutic settings, particularly through its capacity to enhance the quality of emotional recall. Studies indicate that individuals report memories as more vivid and positive under the influence of MDMA compared to a placebo. Such findings offer insights into how these substances might be leveraged to support mental health, fostering greater connectivity or emotional processing capability.